[Proposed method for the treatment of tuberculosis with combined isoniazid, glutamic acid, nicotinamide and methionine; clinical observations on laryngopulmonary tuberculosis and biological considerations].
D000900:Anti-Bacterial Agents; D005971:Glutamates / Q000627:therapeutic use*; D018698:Glutamic Acid; D007538:Isoniazid / Q000627:therapeutic use*; D008715:Methionine / Q000627:therapeutic use*; D009525:Niacin / Q000031:analogs & derivatives; D009536:Niacinamide; D009539:Nicotinic Acids; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary / Q000628:therapy*
D000900:Anti-Bacterial Agents; D005971:Glutamates; D009539:Nicotinic Acids; D009536:Niacinamide; D009525:Niacin; D018698:Glutamic Acid; D008715:Methionine; D007538:Isoniazid
GLUTAMATES/therapeutic use; ISONIAZID/therapeutic use; METHIONINE/therapeutic use; NICOTINIC ACID/related compounds; TUBERCULOSIS, PULMONARY/therapy
Proposta di uno schema di trattamento antitubercolare con le miscele isoniazide-ac. glutammico e nicotinammide-metionina; osservazioni cliniche sulla TBC laringo-polmonare e considerazioni biologiche.